540937 — Medico Remedies Income Statement
0.000.00%
- IN₹3.97bn
- IN₹4.09bn
- IN₹1.51bn
- 63
- 13
- 38
- 28
Annual income statement for Medico Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,224 | 1,210 | 1,404 | 1,449 | 1,509 |
| Cost of Revenue | |||||
| Gross Profit | 302 | 337 | 356 | 350 | 319 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,188 | 1,159 | 1,335 | 1,349 | 1,390 |
| Operating Profit | 35.8 | 51.3 | 69 | 100 | 120 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 36.9 | 65.5 | 101 | 113 | 135 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 25.9 | 48.9 | 72.4 | 82.9 | 101 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 25.9 | 48.9 | 72.4 | 82.9 | 101 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 25.9 | 48.9 | 72.4 | 82.9 | 101 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.25 | 0.589 | 0.873 | 0.999 | 1.22 |